Analyst firms · UBS · MEDP
UBS MEDP price target and rating history
Medpace Holdings Inc. (MEDP) · Health Care
UBS rates Medpace Holdings Inc. (MEDP) Neutral with a $673 price target, as of its latest action on Sep 30, 2026. It has published 6 rating actions on MEDP since September 2022, including 2 upgrades and 2 downgrades. Across 7 firms with a MEDP price target in the last 12 months, the median target is $522. UBS's $673 is 29% above that.
- Current rating
- Neutral
- Price target
- $673
- Median target, all firms
- $522
- Actions on MEDP
- 6
UBS price target on MEDP
Every UBS rating on MEDP
- Sep 30, 2026
- Jul 29, 2025
- Sep 27, 2024
- Feb 15, 2024
- Oct 27, 2022
- Sep 7, 2022
How other firms rate MEDP
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| UBS | Neutral | $673 | Sep 30, 2026 |
| Robert W. Baird | Neutral | $547 | Jul 8, 2026 |
| Jefferies | Hold | $515 | Jul 7, 2026 |
| Barclays | Equal Weight | $500 | Mar 6, 2026 |
| RBC Capital Markets | Outperform | $522 | Mar 3, 2026 |
| TD Cowen | Hold | $419 | Feb 18, 2026 |
| BMO Capital Markets | Market Perform | $600 | Nov 13, 2025 |
Questions about UBS and MEDP
- What is UBS's price target for MEDP?
- UBS's latest stated price target for Medpace Holdings Inc. (MEDP) is $673, from its action on Sep 30, 2026.
- What is UBS's rating on MEDP?
- UBS rates MEDP Neutral, a neutral rating, as of Sep 30, 2026.
- When did UBS last change its view on MEDP?
- On Sep 30, 2026, UBS resumes coverage at Neutral, price target $673.
- How does UBS's MEDP target compare with other analysts?
- Across 7 firms with a MEDP price target in the last 12 months, the median target is $522. UBS's $673 is 29% above that.
More MEDP rating histories
All UBS ratingsMEDP news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.